Huber, Matthias <br/><br/>
Pharmacokinetics and safety of olmesartan medoxomil in combination with glibenclamide in healthy volunteers.  [electronic resource] 

 -  Clinical and experimental hypertension (New York, N.Y. : 1993)  Oct 2006 
 - 631-43 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase I; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1064-1963 
<br/><br/><label>Standard No.: </label>10.1080/10641960600946171  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Antihypertensive Agents--adverse effects<br/>Area Under Curve<br/>Cross-Over Studies<br/>Diabetes Mellitus, Type 2--drug therapy<br/>Dose-Response Relationship, Drug<br/>Drug Therapy, Combination<br/>Glyburide--adverse effects<br/>Humans<br/>Hypertension--drug therapy<br/>Imidazoles--adverse effects<br/>Male<br/>Middle Aged<br/>Olmesartan Medoxomil<br/>Tetrazoles--adverse effects